Shanghai Bao Pharmaceuticals Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Shanghai Bao Pharmaceuticals Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors (NCT07036185) | Shanghai Bao Pharmaceuticals Co., Ltd. | 2025-06-24 |
| Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns (NCT07025408) | Shanghai Bao Pharmaceuticals Co., Ltd. | 2025-06-16 |
| A Clinical Trial With KJ103 in Anti-GBM Disease (NCT06607016) | Shanghai Bao Pharmaceuticals Co., Ltd. | 2024-10-21 |
| Hyaluronidase Assisted Subcutaneous Infusion (NCT06604546) | Shanghai Bao Pharmaceuticals Co., Ltd. | 2024-03-28 |
| A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults (NCT05274659) | Shanghai Bao Pharmaceuticals Co., Ltd. | 2022-05-19 |
Track Shanghai Bao Pharmaceuticals Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.